Physician profile
Chaim Y Mandelbaum
NPI 1215075908
$17,522.52
in general payments reported to CMS, 2019-2025
56 companies · $2,379 in 2025
The $2,379 reported for 2025 was more than what 88% of Public Health & General Preventive Medicine providers received nationally (typical 2025 total: $95.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,140 · 2020: $1,814 · 2021: $3,422 · 2022: $2,499 · 2023: $2,451 · 2024: $1,818 · 2025: $2,379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,648.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,385.54 | 2019-2025 | Relistor |
| Abbvie INC. | $1,708.86 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $1,576.70 | 2019-2025 | Xtampza |
| Nevro Corp. | $1,301.32 | 2019-2023 | Senza |
| Scilex Pharmaceuticals INC. | $935.48 | 2021-2025 | Ztlido |
| Amgen INC. | $918.31 | 2019-2021 | |
| Pfizer INC. | $671.65 | 2019-2025 | |
| Horizon Therapeutics Plc | $659.84 | 2019-2022 | |
| Mdd US Operations, LLC | $601.51 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $591.93 | 2023-2025 | Horizant, Horizant |
| Allergan, INC. | $564.60 | 2019-2022 | |
| Medtronic, INC. | $491.49 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Daiichi Sankyo INC. | $440.18 | 2019 | |
| Boston Scientific Corporation | $414.34 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Redhill Biopharma INC. | $317.08 | 2020-2022 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chaim Mandelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.